Phagocytosis and intracellular killing of heterogeneous vancomycin-intermediate Staphylococcus aureus strains

Journal of Medical Microbiology

Volumn 61, Issue 2, 2012, Pages 198-203

  Méhes, Leonóra ^a   Taskó, Szilvia ^a   Székely, Annamária ^a   Tóth, Ákos ^b   Ungvári, Erika ^b   Erdei, Irén ^a   Dombrádi, Zsuzsanna ^a   Szabó, Judit ^a   Maródi, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTAZIDIME; CEFTRIAXONE; CLINDAMYCIN; FLUCONAZOLE; RIFAMPICIN; TIGECYCLINE; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; AUTOPSY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BLOOD CULTURE; BODY SURFACE; BONE MARROW DEPRESSION; BRONCHUS SECRETION; CANDIDA; CANDIDIASIS; CASE REPORT; CATHETER INFECTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EPILEPSY; EPSILOMETER TEST; FEMALE; GENE CASSETTE; GRANULOCYTE; HEART VENTRICLE ARRHYTHMIA; HEMODIALYSIS; HETEROGENOUS VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; HETEROGENOUS VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS INFECTION; HUMAN; HUMAN CELL; INCISION; INTRACELLULAR KILLING; INTRAVENOUS CATHETER; ISCHEMIA; JUGULAR VEIN; LUNG ABSCESS; MALE; MENTAL DEFICIENCY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NECROTOMY; NONHUMAN; NOSE SMEAR; PARENTERAL NUTRITION; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; QUADRIPLEGIA; REPEAT PROCEDURE; RETROPHARYNGEAL ABSCESS; SEIZURE; SEPSIS; SKIN TRANSPLANTATION; SPLEEN ABSCESS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL TECHNIQUE; THORAX RADIOGRAPHY; THROAT CULTURE; TRACHEOTOMY;

ADULT; ANTI-BACTERIAL AGENTS; BLOOD BACTERICIDAL ACTIVITY; CELLS, CULTURED; FEMALE; GRANULOCYTES; HUMANS; MALE; MICROBIAL VIABILITY; MIDDLE AGED; MOLECULAR TYPING; PHAGOCYTOSIS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE; YOUNG ADULT;

EID: 84855973537     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.029421-0     Document Type: Article

References (27)

1. Boelaert, J. R. (1994). Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review. J Chemother 6 (Suppl. 2), 19-24.
2. Brown, D. F. J., Edwards, D. I., Hawkey, P. M., Morrison, D., Ridgway, G. L., Towner, K. J. & Wren, M. W. on behalf of the Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association (2005). Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 56, 1000-1018.
3. CDC (1997). Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. MMWR Morb Mortal Wkly Rep 46, 765-766.
4. CLSI (2009). Performance Standards for Antimicrobial Susceptibility Testing; 19th Informational Supplement. M100-S19. Wayne, PA: Clinical and Laboratory Standards Institute.
5. Enright, M. C., Day, N. P., Davies, C. E., Peacock, S. J. & Spratt, B. G. (2000). Multilocus sequence typing for characterization of methicil- lin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38, 1008-1015.
6. Garnier, F., Chainier, D., Walsh, T., Karlsson, A., Bolmstrom, A., Grelaud, C., Mounier, M., Denis, F. & Ploy, M. C. (2006). A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital. J Antimicrob Chemother 57, 146-149.
7. Gemmell, C. G. (2004). Glycopeptide resistance in Staphylococcus aureus: is it a real threat? J Infect Chemother 10, 69-75.
8. Goldblum, S. E., Reed, W. P., Ulrich, J. A. & Goldman, R. S. (1978). Staphylococcal carriage and infections in hemodialysis patients. Dial Transplant 7, 1140-1163.
9. Gould, I. M. (2008). Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. Int J Antimicrob Agents 31 (Suppl. 2), 1-9.
10. Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y. & Kobayashi, I. (1997a). Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350, 1670-1673.
11. Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T. & Tenover, F. C. (1997b). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40, 135-136.
12. Jones, R. N. (2006). Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/ static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin Infect Dis 42 (Suppl. 1), S13-S24.
13. Maródi, L., Leijh, P. C. J. & Van Furth, R. (1983). A micromethod for the separate evaluation of phagocytosis and intracellular killing of Staphylococcus aureus by human monocytes and granulocytes. J Immunol Methods 57, 353-361.
14. Maródi, L., Leijh, P. C. & van Furth, R. (1984). Characteristics and functional capacities of human cord blood granulocytes and monocytes. Pediatr Res 18, 1127-1131.
15. Maródi, L., Schreiber, S., Anderson, D. C., MacDermott, R. P., Korchak, H. M. & Johnston, R. B., Jr (1993). Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest 91, 2596-2601.
16. Maródi, L., Káposzta, R., Tóth, J. & László, A. (1995). Impaired microbicidal capacity of mononuclear phagocytes from patients with type I Gaucher disease: partial correction by enzyme replacement therapy. Blood 86, 4645-4649.
17. Maródi, L., Tournay, C., Káposzta, R., Johnston, R. B., Jr & Moguilevsky, N. (1998). Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor. Infect Immun 66, 2750-2754.
18. Maródi, L., Káposzta, R. & Nemes, E. (2000). Survival of group B streptococcus type III in mononuclear phagocytes: differential regulation of bacterial killing in cord macrophages by human recom- binant gamma interferon and granulocyte-macrophage colonystimulating factor. Infect Immun 68, 2167-2170.
19. Maródi, L., Goda, K., Palicz, A. & Szabó, G. (2001). Cytokine receptor signalling in neonatal macrophages: defective STAT-1 phosphoryla- tion in response to stimulation with IFN-c. Clin Exp Immunol 126, 456-460.
20. Oliveira, D. C. & de Lencastre, H. (2002). Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 46, 2155-2161.
21. Ploy, M. C., Grélaud, C., Martin, C. L., de Lumley, L. & Denis, F. (1998). First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 351, 1212.
22. Sakoulas, G., Moellering, R. C., Jr & Eliopoulos, G. M. (2006). Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Clin Infect Dis 42 (Suppl. 1), S40-S50.
23. Song, J.-H., Hiramatsu, K., Suh, J. Y., Ko, K. S., Ito, T., Kapi, M., Kiem, S., Kim, Y.-S., Oh, W. S. & other authors (2004). Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 48, 4926-4928.
24. Szabó, J. (2009). hVISA/VISA: diagnostic and therapeutic problems. Expert Rev Anti Infect Ther 7, 1-3.
25. Szabó, J., Dombrádi, Z., Dobay, O., Orosi, P., Kónya, J., Nagy, K. & Rozgonyi, F. (2009). Phenotypic and genetic characterisation of methicillin-resistant Staphylococcus aureus strains isolated from the university hospitals of Debrecen. Eur J Clin Microbiol Infect Dis 28, 129-136.
26. Tóth, Á., Kispál, G., Ungvári, E., Violka, M., Szeberin, Z., Pászti, J., Molnár, K., Gacs, M. & Fuzi, M. (2008). First report of heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) causing fatal infection in Hungary. J Chemother 20, 655-656.
27. Walsh, T. R., Bolmstrom, A., Qwarnstrom, A., Ho, P., Wootton, M., Howe, R. A., MacGowan, A. P. & Diekema, D. (2001). Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 39, 2439-2444.